nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—AOC3—peripheral nervous system—amyotrophic lateral sclerosis	0.0809	0.172	CbGeAlD
Hydralazine—RYR2—hindbrain—amyotrophic lateral sclerosis	0.0785	0.167	CbGeAlD
Hydralazine—RYR2—brainstem—amyotrophic lateral sclerosis	0.045	0.0959	CbGeAlD
Hydralazine—RYR2—medulla oblongata—amyotrophic lateral sclerosis	0.0314	0.0669	CbGeAlD
Hydralazine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0254	0.0482	CcSEcCtD
Hydralazine—RYR2—nervous system—amyotrophic lateral sclerosis	0.0236	0.0502	CbGeAlD
Hydralazine—RYR2—central nervous system—amyotrophic lateral sclerosis	0.0227	0.0484	CbGeAlD
Hydralazine—RYR2—cerebellum—amyotrophic lateral sclerosis	0.0222	0.0473	CbGeAlD
Hydralazine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0202	0.0383	CcSEcCtD
Hydralazine—AOC3—medulla oblongata—amyotrophic lateral sclerosis	0.0189	0.0403	CbGeAlD
Hydralazine—RYR2—brain—amyotrophic lateral sclerosis	0.018	0.0384	CbGeAlD
Hydralazine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0306	CcSEcCtD
Hydralazine—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0299	CcSEcCtD
Hydralazine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0292	CcSEcCtD
Hydralazine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0288	CcSEcCtD
Hydralazine—P4HA1—medulla oblongata—amyotrophic lateral sclerosis	0.0151	0.0322	CbGeAlD
Hydralazine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0271	CcSEcCtD
Hydralazine—AOC3—nervous system—amyotrophic lateral sclerosis	0.0142	0.0302	CbGeAlD
Hydralazine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0268	CcSEcCtD
Hydralazine—AOC3—central nervous system—amyotrophic lateral sclerosis	0.0137	0.0291	CbGeAlD
Hydralazine—P4HA1—spinal cord—amyotrophic lateral sclerosis	0.0135	0.0287	CbGeAlD
Hydralazine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0255	CcSEcCtD
Hydralazine—AOC3—cerebellum—amyotrophic lateral sclerosis	0.0133	0.0285	CbGeAlD
Hydralazine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0248	CcSEcCtD
Hydralazine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0116	0.022	CcSEcCtD
Hydralazine—P4HA1—nervous system—amyotrophic lateral sclerosis	0.0113	0.0242	CbGeAlD
Hydralazine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0214	CcSEcCtD
Hydralazine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0211	CcSEcCtD
Hydralazine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0211	CcSEcCtD
Hydralazine—P4HA1—central nervous system—amyotrophic lateral sclerosis	0.0109	0.0233	CbGeAlD
Hydralazine—AOC3—brain—amyotrophic lateral sclerosis	0.0108	0.0231	CbGeAlD
Hydralazine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0204	CcSEcCtD
Hydralazine—P4HA1—cerebellum—amyotrophic lateral sclerosis	0.0107	0.0228	CbGeAlD
Hydralazine—Depression—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0201	CcSEcCtD
Hydralazine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0197	CcSEcCtD
Hydralazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0196	CcSEcCtD
Hydralazine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0192	CcSEcCtD
Hydralazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00989	0.0188	CcSEcCtD
Hydralazine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0181	CcSEcCtD
Hydralazine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00947	0.018	CcSEcCtD
Hydralazine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00947	0.018	CcSEcCtD
Hydralazine—P4HA1—brain—amyotrophic lateral sclerosis	0.00867	0.0185	CbGeAlD
Hydralazine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00854	0.0162	CcSEcCtD
Hydralazine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00796	0.0151	CcSEcCtD
Hydralazine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0147	CcSEcCtD
Hydralazine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00769	0.0146	CcSEcCtD
Hydralazine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00766	0.0145	CcSEcCtD
Hydralazine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00761	0.0145	CcSEcCtD
Hydralazine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00747	0.0142	CcSEcCtD
Hydralazine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00742	0.0141	CcSEcCtD
Hydralazine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0139	CcSEcCtD
Hydralazine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00705	0.0134	CcSEcCtD
Hydralazine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00705	0.0134	CcSEcCtD
Hydralazine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00703	0.0133	CcSEcCtD
Hydralazine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00697	0.0132	CcSEcCtD
Hydralazine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00676	0.0128	CcSEcCtD
Hydralazine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00662	0.0126	CcSEcCtD
Hydralazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0066	0.0125	CcSEcCtD
Hydralazine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0122	CcSEcCtD
Hydralazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00632	0.012	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0117	CcSEcCtD
Hydralazine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00607	0.0115	CcSEcCtD
Hydralazine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00603	0.0114	CcSEcCtD
Hydralazine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00595	0.0113	CcSEcCtD
Hydralazine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0112	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00584	0.0111	CcSEcCtD
Hydralazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00578	0.011	CcSEcCtD
Hydralazine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0106	CcSEcCtD
Hydralazine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00537	0.0102	CcSEcCtD
Hydralazine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00534	0.0101	CcSEcCtD
Hydralazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00946	CcSEcCtD
Hydralazine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00908	CcSEcCtD
Hydralazine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00878	CcSEcCtD
Hydralazine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00849	CcSEcCtD
Hydralazine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00816	CcSEcCtD
Hydralazine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00809	CcSEcCtD
Hydralazine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00809	CcSEcCtD
Hydralazine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00804	CcSEcCtD
Hydralazine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00402	0.00763	CcSEcCtD
Hydralazine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00301	0.00641	CbGeAlD
Hydralazine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00289	0.00617	CbGeAlD
Hydralazine—RYR2—Stimuli-sensing channels—TRPM7—amyotrophic lateral sclerosis	0.000846	0.195	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000552	0.127	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000484	0.111	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000312	0.0717	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000312	0.0717	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000312	0.0717	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IGFBP3—amyotrophic lateral sclerosis	0.000249	0.0573	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.000202	0.0465	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000192	0.0442	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000161	0.0371	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000124	0.0285	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000105	0.0242	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000105	0.0242	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.38e-05	0.0216	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.06e-05	0.0185	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	6.84e-05	0.0157	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	6.81e-05	0.0157	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.77e-05	0.00407	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.91e-06	0.00182	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.81e-06	0.0018	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.06e-06	0.0014	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.06e-06	0.0014	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.55e-06	0.00128	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.16e-06	0.00119	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.85e-06	0.00112	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.38e-06	0.00101	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.32e-06	0.000765	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.07e-06	0.000706	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.52e-06	0.00058	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-06	0.000311	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-06	0.000286	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-06	0.000235	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.01e-07	0.000161	CbGpPWpGaD
